← FDA Drug Approvals (Drugs@FDA)
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2023-07-31
Drug application
- FDA Application #
ANDA205981- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Generic name
- SAXAGLIPTIN AND METFORMIN
- Active ingredients
- METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MYLAN
- Manufacturer
- Mylan Pharmaceuticals Inc.
- First approval
- 2023-07-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown